




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=7477ae68-a2db-444b-a0b2-e21d88347930</link>
        <description>Clinical Topic Feed: Cardiac Surgery</description>
        <language>en</language>

        

                <item>
                    <title>MERCURI-2: Dapagliflozin Before Cardiac Surgery Lowers Postoperative AKI Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/MERCURI-2</link>                    <description>Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA.</description>
                    <pubdate>1786471800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PARTNER 3: 7-Year TAVR vs. SAVR Outcomes in Low-Risk Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/PARTNER-3</link>                    <description>Both TAVR and SAVR were associated with a sustained, substantial improvement in patient-reported health status among patients with severe aortic stenosis (AS) considered at low risk, according to the seven-year outcomes of the PARTNER 3 trial published July 29 in JACC.</description>
                    <pubdate>1785862800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Wide Variation in Antithrombotic Regimens After Valve-in-Valve TAVR | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/Wide-Variation-in-Antithrombotic-Regimens</link>                    <description>There is wide variation in antithrombotic regimens after valve-in-valve (ViV) TAVR and no significant differences in outcomes, according to a study published July 27 in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1785780360000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For August 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1785581280000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Indexing Ascending Aortic Dimensions to Height vs. Absolute Diameter to Identify High-Risk Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/28/17/19/Indexing-Ascending-Aortic-Dimensions</link>                    <description>Indexing ascending aortopathy (AA) to height better identifies patients, especially women, who could benefit from earlier surgery rather than absolute diameters, according to a recent study published in JACC: Advances.</description>
                    <pubdate>1785325260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Higher TAVR Volume Associated With Lower Complications, Not Lower Failure to Rescue Rates | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/27/15/09/Higher-TAVR-Volume</link>                    <description>Higher annualized TAVR volume is associated with lower complication rates but not with lower failure to rescue (FTR) rates, according to a recent study published in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1785324900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Procedure-Related Infective Endocarditis is Rare, Not Associated With Antibiotic Prophylaxis Dosing</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/20/14/38/Procedure-Related-Infective-Endocarditis-is-Rare</link>                    <description>There was no significant association between antibiotic prophylaxis (ABP) dosing before congenital cardiac catheterization and early infective endocarditis (IE) post procedure, according to a retrospective analysis recently published in JACC: Advances. Overall, IE was rare and largely dependent on procedure type.</description>
                    <pubdate>1784730900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>The Importance of Enhanced Radiation Protections in Cath Labs</title>
<link>/Latest-in-Cardiology/Articles/2026/07/22/13/15/eagles-eye-view-22jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1784726220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC, SCAI and STS Submit Feedback on Proposed TAVR NCD</title>
<link>/Latest-in-Cardiology/Articles/2026/07/15/17/40/ACC-SCAI-and-STS-Submit-Feedback-on-Proposed-TAVR-NCD</link>                    <description>The ACC, along with the Society for Cardiovascular Angiography &amp;amp; Interventions (SCAI) and the Society of Thoracic Surgeons (STS), submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) on July 15 regarding the proposed decision memo for the National Coverage Determination (NCD) for TAVR.</description>
                    <pubdate>1784138100000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#39;s Eye View: The SHaRE Registry as a Predictor of MACE</title>
<link>/Latest-in-Cardiology/Articles/2026/07/15/14/19/eagles-eye-view-15jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at the feasibility of mechanical leaflet splitting in high-risk patients undergoing valve-in-valve transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1784125200000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>